These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2606117)

  • 1. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
    Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
    Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
    Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
    Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV; Koistinen MJ; Takkunen JT
    Am J Cardiol; 1992 Feb; 69(5):498-502. PubMed ID: 1736614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
    Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T; Borggrefe M; Haverkamp W; Chen X; Breithardt G
    Circulation; 1992 Jul; 86(1):29-37. PubMed ID: 1617780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of sotalol in supraventricular arrhythmias.
    Brugada P; Smeets JL; Brugada J; Farré J
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():619-23. PubMed ID: 2275892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
    Feld GK; Nademanee K; Weiss J; Stevenson W; Singh BN
    J Am Coll Cardiol; 1984 May; 3(5):1298-307. PubMed ID: 6707383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases.
    Romito G; Gemma N; Dondi F; Mazzoldi C; Fasoli S; Cipone M
    J Vet Cardiol; 2024 Jun; 53():20-35. PubMed ID: 38608438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
    Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
    Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.